SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,201,864 | -28.7% | 847,054 | +26.4% | 0.04% | -28.3% |
| Q2 2023 | $4,489,583 | +14.9% | 670,087 | +11.7% | 0.05% | 0.0% |
| Q1 2023 | $3,906,000 | -63.7% | 600,000 | -52.4% | 0.05% | -63.2% |
| Q4 2022 | $10,758,949 | +150.7% | 1,261,307 | +55.2% | 0.14% | +140.0% |
| Q3 2022 | $4,292,000 | +1364.8% | 812,899 | +872.7% | 0.06% | +1100.0% |
| Q1 2022 | $293,000 | -91.1% | 83,571 | -83.1% | 0.01% | -89.4% |
| Q4 2021 | $3,289,000 | -22.5% | 493,895 | +16.1% | 0.05% | -31.9% |
| Q3 2021 | $4,244,000 | -63.6% | 425,261 | +12.6% | 0.07% | -68.3% |
| Q2 2021 | $11,665,000 | +29.4% | 377,631 | +82.7% | 0.22% | +9.0% |
| Q1 2021 | $9,018,000 | -9.7% | 206,683 | -4.1% | 0.20% | -24.5% |
| Q4 2020 | $9,988,000 | – | 215,536 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |